We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
Medica 2024
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Cancer Drug Discovered in Sunflower Seed Protein

By LabMedica International staff writers
Posted on 04 Apr 2011
Australian scientists have demonstrated sunflower proteins and their processing machinery are commandeered to produce rogue protein rings in a discovery that could provide avenues to less expensive, plant-based drug manufacturing.

Dr. Joshua Mylne hopes his research has found another use for these plants through the manufacture of cheap therapeutic drugs. Dr. Joshua Mylne and Prof. David Craik, both from the University of Queensland's (UQ) Institute for Molecular Bioscience (Brisbane, Australia), unraveled the manner in which sunflower seeds assemble protein rings, one of which has previously demonstrated potential as a drug for cancer.

The study, published March 21, 2011, in the international journal Nature Chemical Biology, revealed that the machinery used to process and mature otherwise dull seed storage proteins is controlled by a protein ring, SFTI, for its own use. Dr. Mylne and Prof. Craik used the model plant Arabidopsis for their research, demonstrating that the sunflower protein-production system could be moved into another species and therefore SFTI could be manufactured in a range of plants.

Whereas this is of interest to researchers by providing an understanding of how new proteins can evolve and how proteins are matured, it has wider applications for drug production. SFTI can be used in its natural form to block breast cancer enzymes, and in a modified form to block enzymes associated with other types of cancer.

These proteins have not been widely used by drug designers despite their potential to fight cancer because of the expense of producing them using conventional, synthetic manufacturing methods.

"Although SFTI and related proteins show great promise as drug templates, the cost to manufacture them is a significant barrier to widespread use,” Dr. Mylne said. "This issue could be solved through plant manufacturing. Seeds are an attractive system for the production of pharmaceuticals, as they are cheap to grow and their contents are stable at room temperature, and sterile inside their coat. There are also established systems in place for their production, harvest, storage, and transportation, meaning they could be the ultimate low-cost drug delivery system.”

Related Links:

University of Queensland Institute for Molecular Bioscience



Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Thyroid ELISA Kit
AESKULISA a-TPO
New
UHF RFID Tag and Inlay
AD-321r6/AD-321r6-P

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries